User:Ngui.dodo/Brivanib alaninate

This is the sandbox page where you will draft your initial Wikipedia contribution.

If you're starting a new article, you can develop it here until it's ready to go live.

If you're working on improvements to an existing article, copy only one section at a time of the article to this sandbox to work on, and be sure to use an edit summary linking to the article you copied from. Do not copy over the entire article. You can find additional instructions here.

Remember to save your work regularly using the "Publish page" button. (It just means 'save'; it will still be in the sandbox.) You can add bold formatting to your additions to differentiate them from existing content.

Bibliography sandbox

Article Draft

Lead

Article body

Article about Brivanib Alaninate ^[1]

References

^ Nakamura, Ikuo; Zakharia, Kais; Banini, Bubu A.; Mikhail, Dalia S.; Kim, Tae Hyo; Yang, Ju Dong; Moser, Catherine D.; Shaleh, Hassan M.; Thornburgh, Sarah R.; Walters, Ian; Roberts, Lewis R. (2014-04-07). Avila, Matias A. (ed.). "Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling". PLoS ONE. 9 (4): e92273. doi:10.1371/journal.pone.0092273. ISSN 1932-6203. PMC 3977817. PMID 24710173.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)

[1] Nakamura, Ikuo; Zakharia, Kais; Banini, Bubu A.; Mikhail, Dalia S.; Kim, Tae Hyo; Yang, Ju Dong; Moser, Catherine D.; Shaleh, Hassan M.; Thornburgh, Sarah R.; Walters, Ian; Roberts, Lewis R. (2014-04-07). Avila, Matias A. (ed.). "Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling". PLoS ONE. 9 (4): e92273. doi:10.1371/journal.pone.0092273. ISSN 1932-6203. PMC 3977817. PMID 24710173.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)

[1]